PHARMACOKINETICS OF BISOPROLOL DURING REPEATED ORAL-ADMINISTRATION TO HEALTHY-VOLUNTEERS AND PATIENTS WITH KIDNEY OR LIVER-DISEASE

被引：55

作者：

KIRCH, W

ROSE, I

DEMERS, HG

LEOPOLD, G

PABST, J

OHNHAUS, EE

机构：

[1] UNIV ESSEN GESAMTHSCH,MED KLIN,D-4300 ESSEN 1,FED REP GER

[2] MED KLIN 3,DARMSTADT,FED REP GER

[3] DEPT CLIN PHARMACOL E MERCK,DARMSTADT,FED REP GER

来源：

CLINICAL PHARMACOKINETICS | 1987年 / 13卷 / 02期

关键词：

D O I：

10.2165/00003088-198713020-00003

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：110 / 117

页数：8

共 15 条

[1]

BUHRING KU, 1986, J CHROMATOGR, V382, P215

[2]

GIBALDI M, 1982, PHARMACOKINETICS

[3] PHARMACOKINETIC AND PHARMACODYNAMIC PROPERTIES OF METOPROLOL IN PATIENTS WITH IMPAIRED RENAL-FUNCTION [J].

JORDO, L ;

ATTMAN, PO ;

AURELL, M ;

JOHANSSON, L ;

JOHNSSON, G ;

REGARDH, CG .

CLINICAL PHARMACOKINETICS, 1980, 5 (02) :169-180

[4] PHARMACOKINETICS OF ATENOLOL IN RELATION TO RENAL-FUNCTION [J].

KIRCH, W ;

KOHLER, H ;

MUTSCHLER, E ;

SCHAFER, M .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 19 (01) :65-71

[5]

KIRCH W, 1982, CLIN NEPHROL, V18, P88

[6] INTERACTION OF BISOPROLOL WITH CIMETIDINE AND RIFAMPICIN [J].

KIRCH, W ;

ROSE, I ;

KLINGMANN, I ;

PABST, J ;

OHNHAUS, EE .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 31 (01) :59-62

[7] CLINICAL-EXPERIENCE WITH ATENOLOL IN PATIENTS WITH CHRONIC LIVER-DISEASE [J].

KIRCH, W ;

SCHAFERKORTING, M ;

MUTSCHLER, E ;

OHNHAUS, EE ;

BRAUN, W .

JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 23 (04) :171-177

[8]

LEOPOLD G, 1982, Clinical Pharmacology and Therapeutics, V31, P243

[9]

LEOPOLD G, 1986, IN PRESS J CLIN PHAR

[10] BETA-ADRENOCEPTOR-BLOCKING AGENTS - PHARMACOKINETIC DIFFERENCES AND THEIR CLINICAL IMPLICATIONS ILLUSTRATED ON PINDOLOL [J].

MEIER, J .

CARDIOLOGY, 1979, 64 :1-13

← 1 2 →